In Tough Times, Corporate VCs Could Pick Up Financing Slack
By Jennifer Boggs
Monday, January 26, 2009
In Hydra Biosciences Inc.'s recent $22 million Series D round, three of its seven venture capital investors were corporate investing arms, a trend that's likely to increase if VC money becomes as hard to find as many industry experts are predicting.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.